CSL’s Seqirus expects to double flu vaccine production at NC plant
Seqirus, a vaccine business owned by Australian biotech CSL, expects production of its influenza vaccine Flucelvax Quadrivalent at a North Carolina manufacturing plan...
IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.